Circulating Markers of Inflammation for Vascular Risk Prediction
- 18 April 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (15) , 1758-1759
- https://doi.org/10.1161/01.cir.101.15.1758
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.Journal of Clinical Investigation, 1998
- A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.Journal of Clinical Investigation, 1998
- Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant ActivityArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wallAtherosclerosis, 1996
- Use of a cDNA microarray to analyse gene expression patterns in human cancerNature Genetics, 1996
- Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.Journal of Clinical Investigation, 1995